Thermo Fisher Scientific | TMO - Cash And Equivalent

Stock Price
542.72
Daily Change
0.36 0.07%
Monthly
-12.06%
Yearly
-5.03%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $9.85B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Henry Schein USD 136M 9M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 1.42B 368M Dec/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Olympus JPY 241.22B 11.32B Jun/2025
Quest Diagnostics USD 432M 113M Sep/2025
Repligen USD 748.75M 39.89M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Stryker USD 3.26B 881M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Veracyte USD 315.57M 96.07M Sep/2025
Waters USD 459.12M 91.9M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025